Live tape
Top 8, mentions 7d9,263GOOGL1,849 mentions▲ +0.04SNDK1,521 mentions▲ +0.11NVDA1,123 mentions▲ +0.08META1,106 mentions▲ +0.03SPCX1,077 mentions▲ +0.09NBIS965 mentions▲ +0.09HTZ837 mentions▲ +0.09VOO785 mentions▲ +0.09

Equity · Healthcare

NAMS

NewAmsterdam Pharma Company N.V. · NasdaqGM

$31.67 +2.13% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 39 sessions
$37.5 $27.5 21 May 17 Jul

The line runs $36 on 21 May through $31.67 on 17 July, on a scale from $27.5 to $37.5. Days the market did not trade hold the previous close, flat.

The chart above plots the price of NAMS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 39 sessions over that window: $36 on 21 May 2026 through $31.67 on 17 July 2026.

Market cap $3.8B
52-week range $21 – $41
Avg volume 263.6K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026

NAMS insider trades

SEC Form 4

NAMS has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 15 September 2025.

Date Insider Type Shares Value
15 Sep 2025 Topper James N Buy 660 $16K
09 Sep 2025 Kooij Louise Frederika Chief Accounting Officer Sell 150,000 $3.87M
08 Sep 2025 Topper James N Buy 1,260 $31K
03 Sep 2025 Kooij Louise Frederika Chief Accounting Officer Sell 18,073 $453K
25 Aug 2025 Kooij Louise Frederika Chief Accounting Officer Sell 8,269 $206K
22 Aug 2025 Kastelein Johannes Jacob Pieter Chief Scientific Officer Sell 50,000 $1.26M
21 Aug 2025 Kastelein Johannes Jacob Pieter Chief Scientific Officer Sell 50,000 $1.21M
11 Aug 2025 Topper James N Buy 471 $11K
16 Jul 2025 Kling Douglas F Chief Operating Officer Sell 51,043 $1.08M
15 Jul 2025 Kling Douglas F Chief Operating Officer Sell 47,569 $1.02M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
09 Sep 2025 Kooij Louise Frederika Chief Accounting Officer Option exercise 150,000 $1.50M
02 Sep 2025 Kooij Louise Frederika Chief Accounting Officer Option exercise 18,073
16 Jul 2025 Kling Douglas F Chief Operating Officer Option exercise 51,043 $556K
15 Jul 2025 Kling Douglas F Chief Operating Officer Option exercise 47,569 $519K

NAMS reported financials

SEC EDGAR XBRL

NAMS reported revenue of $22.5M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$203.8M.

Figure Reported Period
Revenue $22.5M 31 Dec 2025 fiscal year
Net income −$203.8M 31 Dec 2025 fiscal year
Diluted EPS −$1.72 31 Dec 2025 fiscal year
Total assets $704.5M 30 Jun 2026 at period end
Total equity $631.4M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

NAMS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.52 $4M
31 Mar 2026 Q1 2026 $-0.40 $3M
31 Dec 2025 FY 2025 $-1.72 $23M
30 Sep 2025 Q3 2025 $-0.61 $0M
30 Jun 2025 Q2 2025 $-0.15 $19M
31 Mar 2025 Q1 2025 $-0.34 $3M
31 Dec 2024 FY 2024 $-2.56 $46M
30 Sep 2024 Q3 2024 $-0.18 $29M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

NAMS institutional holders

SEC Form 13F

11 of the 45 institutional funds we track reported a NAMS position for the quarter ended 30 Jun 2026 — a combined $412.6M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Viking Global Investors Held (±25%) 4,203,567 $142.5M
Maverick Capital Added +49.5% shares 3,267,802 $110.7M
Duquesne Family Office Held (±25%) 3,070,146 $104.0M
Citadel Advisors Held (±25%) −9.3% shares 645,805 $21.9M
Millennium Management Added +65.1% shares 501,614 $17.0M
Point72 Asset Management New position 168,901 $5.7M
D. E. Shaw & Co. New position 120,561 $4.1M
Man Group New position 80,832 $2.7M
Tudor Investment Corp New position 79,460 $2.7M
AQR Capital Management Added +118.5% shares 22,691 $769K

Showing the 10 largest of 11 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

NAMS fails-to-deliver

SEC CNS data

On 29 Jul 2026, 138 shares of NAMS failed to deliver (about $4K).

Settlement date Shares failed Notional % of shares out
29 Jul 2026 138 $4K <0.001%
24 Jul 2026 500 $15K <0.001%
23 Jul 2026 500 $16K <0.001%
22 Jul 2026 500 $16K <0.001%
21 Jul 2026 3,976 $118K 0.003%
17 Jul 2026 2 $62 <0.001%
08 Jul 2026 1,911 $71K 0.002%

Source: SEC fails-to-deliver (CNS) data